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Abstract
Background: The liver is the central organ for xenobiotic metabolism (XM) and is regulated by nuclear receptors such as
CAR and PXR, which control the metabolism of drugs. Here we report that gut microbiota influences liver gene expression
and alters xenobiotic metabolism in animals exposed to barbiturates.
Principal findings: By comparing hepatic gene expression on microarrays from germfree (GF) and conventionally-raised
mice (SPF), we identified a cluster of 112 differentially expressed target genes predominantly connected to xenobiotic
metabolism and pathways inhibiting RXR function. These findings were functionally validated by exposing GF and SPF mice
to pentobarbital which confirmed that xenobiotic metabolism in GF mice is significantly more efficient (shorter time of
anesthesia) when compared to the SPF group.
Conclusion: Our data demonstrate that gut microbiota modulates hepatic gene expression and function by altering its
xenobiotic response to drugs without direct contact with the liver.
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Introduction
Data accumulated over the last decade strongly support that the
commensal intestinal flora has profound effects on the physiology
of the host. In the majority of studies to date, these effects have
been studied locally in the intestine, where members of the
microbiota are known to affect angiogenesis, development of the
intestinal epithelium as well as the mucosa associated lymphoid
tissue (MALT) [1–4]. However, more recent work is indicating
that the flora may be exerting effects beyond the intestine and
studies have indicated that patients with some chronic inflamma-
tory disorders such as obesity, Type I diabetes and Crohn’s disease
display an altered gut flora that may be influencing the phenotype
of these disorders [5–8].
The liver is an essential organ in mammals and the central
organ for metabolic processes including xenobiotic metabolism.
Moreover, the liver also overlooks and tunes homeostasis of
cholesterol, bile acids, sterols, lipids and heme. Nutrients and
metabolites are transported from the intestine to the liver via the
afferent pathways, the vena portae and the lymphatic system. In
contrast, the efferent bile ducts transport molecules from the liver
to the intestine thereby closing the loop and giving rise to the
enterohepatic circulation system. Thus, a vast array of metabolites
circulates between the intestine and liver. Hence, the enterohe-
patic circulation is a critical transport system in order to allow the
liver to play its central role in mammalian metabolism. Previous
data have shown that intestinal microbes can tune the profile of
lipids in the enterohepatic circuit thus having consequences for
liver metabolism [9–12]. The direct effects of microorganisms on
the cholesterol-derived compounds and their hepatic recirculation
renders hepatic metabolism a plausible systemic physiological
function regulated by intestinal microbiota, without direct contact
with the bacteria.
Xenobiotic metabolism in the liver is largely regulated by
nuclear receptors (NRs), primarily the ‘‘xenosensors’’ Constitutive
Active/Androstane Receptor (CAR), and the Pregnane X receptor
(PXR) [13]. In addition, CAR and PXR also regulate homeostasis
of cholesterol, bile acids, sterols, lipids, heme and other
endogenous hydrophobic molecules. They form a NR network
regulating a number of essential liver functions jointly with the bile
acid activated Farnesoid X receptor (FXR) and the liver X
receptor (LXR) [13]. The cross-reactivity of lipid homeostasis and
xenobiotic metabolism pathways was recently pin-pointed to
converge at the transcription factor Insig-1 being regulated via
both CAR and PXR [14]. This report elegantly provided an
explanation as to how an activation of xenobiotic metabolism
regulators like CAR and PXR induce Insig-1 by CAR and PXR
which may explain the negative effects of some drugs on hepatic
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lipid levels [14]. Thus, the pathways for xenobiotic metabolism
and homeostasis of sterols, lipids, bile acids, heme and energy
cross-react in the liver through NRs [14,15].
Recently, exploiting germfree (GF) animals, we reported that
several NRs (including CAR) in the colonic epithelium are
subjected to regulation by the microbiota [16]. The effects of a
complete intestinal microbiota on liver metabolites and xenobiotic
compounds have been studied since the 1960ies. However, this
field has been largely neglected in the recent decades. Motivated
by this and with the overall aim of gaining insight into potential
molecular mechanisms by which the intestinal microbiota might
influence the metabolic potential of the liver, we undertook an
investigation of the molecular effects of a normal intestinal
microflora on the liver and its function. Our results show that
the microbiota have extensive effects on hepatic gene expression in
mice, demonstrated by higher expression of a number of key genes
in metabolic function, most notably CAR, in GF mice as
compared to conventionally-raised specific pathogen-free (SPF)
animals. This effect is most likely a result of microbial metabolism
of endogenous compounds in the intestine. The physiological
effects of the gene expression results were confirmed by examining
the metabolism of the xenobiotic pentobarbital, in GF and SPF
mice. Our results connect the intestinal bacteria to xenobiotic
metabolism in the liver and supply a potential mechanism for this
effect.
Results
Effect of intestinal microbiota on gene expression in liver
Gene expression in the liver was initially assessed on 60-mer
oligo microarrays on RNA from GF and SPF male NRMI mice
(n = 4/group; NCBI GEO platform accession GSE14689, accord-
ing to MIAME guidelines). The genes that were significantly
differentially expressed were selected for quantitative PCR-
verification based on the following criteria: q,5% (false discovery
rate), fold change (FC) of 2#FC$22 and the presence of a human
orthologue resulting in 380 genes. These selected genes were
reanalyzed on TLDA or using individual qRT-PCR assays (n =
7 mice/group), and 112 genes were verified to be significantly
differentially expressed (q,5%) in GF compared to SPF livers
(Table S1). Using Ingenuity Pathway Analysis (IPA) we examined
the relation between these 112 genes and the most significant
canonical pathways or biological networks involved. As a result,
the most abundant categories of differentially expressed genes are
the endobiotic and the xenobiotic metabolism groups (Figure 1).
Notably, biological network analysis shows that several of the
genes modulated by the intestinal microbiota are regulated
through a general xenobiotic regulator, the nuclear receptor
CAR (Figure 2). CAR was 1.6-fold lower expressed in the SPF
compared to GF mice, and several CAR-regulated genes were
differentially expressed in the same direction. Some members of
the cytochrome P450 family, involved in the metabolism of drugs,
chemical carcinogens, and endogenous chemicals were also down-
regulated in the SPF mice. Cyp2b9, a major P450 in the mouse
liver was 46.5-fold lower expressed in the SPF compared to GF
mice. Other P450s namely Cyp2a4, Cyp2b13, Cyp2c38 and
Cyp4a14 were 6.8-fold, 3.5-fold, 2.8-fold and 8.4-fold lower
expressed in SPF mice respectively. Interestingly, the P450
oxidoreductase (POR), the unique electron donor for all type II
cytochrome P450 enzymes, was 2.9-fold lower expressed in the
SPF animals compared to GF (Figure 3). The NR farnesoid-X
receptor, FXR was also 1.3-fold lower expressed in the SPF
compared to GF mice. Another group of genes that are expressed
at lower levels in SPF mice are key regulatory genes in circadian
rhythm, notably the PAR bZip genes, Dbp, Tef and Hlf, that were
6-fold, 2.5-fold and 4-fold lower in SPF compared to GF mice,
Figure 1. Canonical Pathways Analysis. Shown are the top fifteen significant canonical pathways as determined by using the Ingenuity Pathway
Analysis software (IngenuityH Systems). The strength of the statistical association is indicated by the length of the bars. The ration value reflects the
proportion of gene elements in the differentially abundant gene list that corresponded to genes in each pathway. The vertical line represents the
threshold of the significance.
doi:10.1371/journal.pone.0006958.g001
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Figure 2. Pathway analysis based on the Ingenuity Pathway Knowledge Base (IPKB). The two highest scoring networks (A) Network 1 and
(B) Network 2 created from the 112 differentially expressed genes list are shown. (C) showed the merged network of Network 1 and Network 2. Nodes
that are not colored are added by IPKB. Colored nodes are shaded by their relative expression, green when lower in GF than SPF and red when higher
expressed in GF compared to SPF, intensity is relative to expression. The shape of the node indicates the major function of the protein. A line denotes
binding of the products of the two genes while a line with an arrow denotes ‘acts on’. A dotted line denotes an indirect interaction. Yellow lines in (C)
denotes connection between Network 1 and Network 2.
doi:10.1371/journal.pone.0006958.g002
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respectively. A related gene, Nfil3 is 3.3-fold higher expressed in
SPF mice. Finally, another gene of relevance to development and
maintenance of neurons, Ntrk2, is 9.8-fold higher expressed in
SPF mice.
Effect of intestinal microbiota on liver function and size
In order to address possible physiological consequences of the
observed differences in gene expression, we studied the xenobiotic
metabolic pathway of barbiturates and compared metabolism of
pentobarbital in GF and SPF mice by monitoring their time of
anesthesia. In line with the higher expression levels of CAR in GF
mice, we observed that GF animals had a significantly shorter time
of anesthesia as scored by the time between loosing and regaining
the righting reflex after barbiturate injection compared to SPF
animals (53 vs. 81 min, Figure 4, p,0.001, Student’s t-test).
Interestingly, in the conventionalized (Conv-D) groups, the
barbiturate-induced anesthesia was similar to the GF group: 48
to 50 min (Figure 4).
We also examined liver weight in relation to body weight (liver/
body weight ratio), given that this ratio is generally inversely
correlated to xenobiotic metabolic capacity. This parameter was
significantly lower in GF mice, 3.7% compared to 4.1% in SPF
(p,0.001, Student’s t-test, Figure 4). Surprisingly, the liver/body
weight ratios for the Conv-D groups were actually higher than
both SPF and GF; 4.5%, 4.3% and 4.6% after 1, 3, and 6 weeks
conventionalization, respectively. However, the differences of all
Conv-D groups compared to GF, and the Conv-D6w vs. SPF
comparison reached statistical significance (Figure 4, p,0.001,
Student’s t-test). In conclusion, for the Conv-D mice the
pentobarbital-induced anesthesia remained similar to the GF
group, while the liver size in relation to body weight turned out to
be more comparable to the SPF group.
Discussion
In the present study, we connect the gut microbiota with liver
gene expression profiles. The most abundant categories of the 112
Figure 3. Selected differentially expressed genes in SPF compared to GF NMRI mice (n=7 animals/group). Fold changes of genes in the
categories (A) Xenobiotic Metabolism and (B) Circadian rhythm, are shown.
doi:10.1371/journal.pone.0006958.g003
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differentially expressed genes are those involved in endobiotic and
xenobiotic metabolism (Figure 1 and Table S1). Thus, we focus
our discussion on key genes reported to have important liver
functions.
Of particular interest was the observation of a network of
modulated genes influenced by a key general xenobiotic regulator:
the NR CAR. CAR was more highly expressed in the livers of GF
compared to SPF mice, and several CAR-regulated genes were
differentially expressed in the same direction. We have previously
shown that CAR is also expressed at higher levels in GF colonic
epithelium, when compared to SPF [16]. In addition, the CAR-
regulated gene POR, coding for the P450 oxidoreductase, the
unique electron donor for all type II cytochrome P450 enzymes, was
more highly expressed in the GF animals compared to SPF.
Currently, we can only speculate on the signals leading to the higher
expression of CAR in the absence of an intestinal microbiota.
However, it is known that levels of bile acids, steroid hormones and
bilirubin are regulated by gut microbiota [9–12,17–19]. In many
cases, these cholesterol-derived metabolites in their unmodified
form, act as ligands or activators of NRs in the liver to control the
endogenous metabolism of the compounds. In the liver, bile acids,
bilirubin and steroid hormones as well as xenobiotic compounds,
activate CAR [13,15,20,21]. Indeed, it has been known for decades
that the intestinal microbiota influences the levels of bilirubin
[18,19], the composition and levels of bile acids [11,12] and the
amount of steroid hormones in feces and serum [9,10,12,17]. GF
animals also have reduced fecal secretion of bile acids and neutral
steroids and increased levels of cholesterol in the liver and serum
[17]. Gustafsson et al. tested the microsomal metabolism of GF and
Conv rats by cholesterol feeding [12]. This leads to steroid and bile
acid profiles in conventional animals that are similar to that of GF.
Interestingly, the high hydroxylase activities characteristic of the GF
rat was only slightly decreased as long as 56 days after
conventionalization. Our results point to a constitutively higher
expression of CAR in the absence of the intestinal microbiota in GF
mice, likely because of the elevated levels of the CAR activators
bilirubin, bile acids and steroid hormones, the relative contributions
of these are so far unknown. This might be a result of the increased
levels of cholesterol, and/or the direct biochemical effects of the
microbiota on these compounds, leading to accumulation.
Figure 4. (A) Average time between loosing and regaining the righting reflex after i.p. injection (45 mg/kg body weight) of
Pentobarbital and (B) Liver/Body weight ratio (%) in GF, Conv-D and SPF NMRI mice. GF: germ-free; Conv-D: conventionalized 1, 3 or 6
weeks; SPF: conventionally-raised specific pathogen free.
doi:10.1371/journal.pone.0006958.g004
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The increased basal level of CAR and its downstream target
genes in GF animals was associated with significant effects on
xenobiotic metabolism as assessed by challenge with pentobarbital.
This challenge resulted in 35% shorter time of barbiturate-induced
anesthesia in GF mice (53 min) compared to SPF (81 min),
indicating a more efficient metabolism of the xenobiotic in GF
animals. Other key regulators of metabolism that might be
involved include the NRs farnesoid-X receptor FXR and
pregnane-X receptor PXR. Interestingly, while the NR FXR
was more highly expressed in the GF, compared to SPF mice, no
significant difference in expression of PXR was detected indicating
that the xenobiotic NRs involved may be differentially regulated
by the gut flora.
Another group of genes of interest are the PAR bZip genes Dbp,
Tef and Hlf. This group of genes are expressed at higher levels in
GF mice and are reported to be key regulatory genes in circadian
rhythm and xenobiotic metabolism [22,23]. In contrast, the bZip
transcription factor Nfil3, is higher expressed in SPF mice. This
regulatory gene is known to be in the opposite phase to the rhythm
of the PAR bZip genes in the liver, as well as in the hypothalamic
suprachiasmatic nucleus (the mammalian circadian rhythm center)
[24]. Furthermore, the PAR bZip genes and Nfil3 also share
overlapping DNA-binding specificity [24]. Importantly, the PAR
bZip genes control expression of two genes essential for xenobiotic
metabolism: aminolevulinic acid synthase (ALAS1) and POR, with
a 2.0-fold and 2.9-fold higher expression in GF mice respectively
[22]. The PAR bZip genes also control the circadian expression
rhythm of CAR [25]. Another important gene in circadian
regulation, the aryl hydrocarbon receptor nuclear translocator like
(arntl or BMAL1) is 7 fold lower expressed in GF mice. This gene
has also been shown to be involved in regulation of xenobiotic
metabolism [26]. Taken together, these data make it tempting to
speculate on the possibility that the gut microbiota may impact on
regulation of the peripheral circadian rhythm of xenobiotic
metabolism, which opens up hitherto unsuspected lines of
research.
An additional liver parameter that differed between GF and
SPF animals was liver weight in relation to body weight, being
significantly lower in GF mice. Our observed association between
lower expression of POR and the three PAR bZip genes; Dbp, Tef
and Hlf, and the higher liver/body weight ratio in SPF are
consistent with results from hepatic POR null mice [27] and PAR
bZip triple knockouts [23] where the liver/body weight ratios are
increased, most likely because of accumulation of lipids. However,
in CAR null animals, the ratio seems to be unaffected in untreated
animals [21].
Another striking observation of our work was the almost 10-fold
higher expression of Ntrk2, the gene encoding the neurotrophic
tyrosine receptor kinase 2 TrkB, in SPF mice. The neurotrophins
are growth factors that promote survival in development and
maintenance of neurons. TrkB is a membrane-bound neurotro-
phin receptor that phosphorylates itself, and members of the
MAPK pathway, after binding of its ligand; the brain-derived
neurotrophin (Bdnf) [28,29]. Interestingly, Ntrk2 or Bndf
homozygous knockouts are not viable, but Bndf heterozygous
knockouts, as well as conditional deletion of Bndf in the postnatal
brain and hypomorphic mice expressing 24% of normal levels of
TrkB all exhibit increased food intake and obesity [28,30–32].
Intriguingly, in the brain, disruption of these molecules have also
been shown to have cognitive effects such as hyperactivity,
increased anxiety and increased locomotive activity [28].
A common approach to confirm microbiota involvement is to
use conventionalization, i.e. to colonize GF mice with a complete
microbiota (Conv-D) and compare them to conventionally-raised
SPF mice. Previous reports indicate that conventionalization for
up to 2 weeks renders Conv-D animals indistinguishable from
animals conventionally-raised from birth [1–3,5]. Thus, the
physiological end-points in our experiments; liver size and
xenobiotic metabolism, were tested in Conv-D mice 1 week, 3
weeks and 6 weeks after conventionalization. Already after one
week, the liver weight increased so that the liver/body weight ratio
was indistinguishable from SPF animals. This effect was even more
pronounced after six weeks conventionalization, where the liver/
body weight ratio was 13% higher than SPF, and as much as 20%
higher than GF. Surprisingly, we were unable to render the rate of
xenobiotic metabolism comparable to SPF animals even after
conventionalization for 6 weeks. This indicates, as shown by B.E.
Gustafsson for bile acids and steroids already in 1975, that the
consistent reduction of microsomal metabolism after microbial
colonization of the adult GF-born animal to the levels of rodents
conventionally-raised from birth need considerable time, more
than six weeks [12]. An alternative explanation is that while
certain microbiota modulated phenomena such as liver weight,
angiogenesis and obesity are subject to microbiota regulation
throughout life; pathways such as regulation of xenobiotic
metabolism may be fixed after a period early in postnatal life
and hence can not be modulated later in life. Exposing young but
not old GF mice to gut microbiota, showed that for the HPA
(hypothalamic-pituitary-adrenal axis) system to become fully
susceptible to inhibitory neural regulation, it must be exposed
gut microbiota at an developmental stage when brain plasticity
may still be preserved [33]. This data support the possibility of a
constraint temporal window in development when gut microbiota
can affect homeostasis.
Our results provide a novel mechanistic explanation for the
effects of the microbiota on xenobiotic/drug metabolism in the
liver. It is tempting to speculate that the effects on drug
metabolism observed here extend to other drugs as well, which
would potentially have immense influence on the general view of
human variation of efficiency of xenobiotic metabolism by the
cytochrome P450-system, an obstacle in pharmacology. Our
findings will also have implications for the described correlation
between xenobiotic metabolizing capacity and longevity [23,34–
36], a possible explanation for the longevity of GF rodents [37]
A curiosity is the described correlation between xenobiotic
metabolizing capacity and longevity, e.g. in the long-lived Little
mouse (homozygous for a missense mutation in the growth
hormone releasing hormone receptor gene, Ghrhr) or in calorie-
restricted mice, with upregulated xenobiotic response [34]. In the
Little mouse, CAR and PXR are not involved in the upregulation
of xenobiotic metabolism (except for Cyp2b10 and Cyp2C38), but
the effect was attributed to increased levels of bile acids and
signaling through FXR. GF mice have a longer lifespan than SPF,
but the effects of calorie restriction were similar on GF and SPF
mice [38] and rats [36,37]. The general theory is that the
accumulation of toxic metabolic by-products is a major contrib-
utor to ageing [36].
To summarize, the lack of intestinal bacteria in GF mice leads to
excess amounts and accumulation of CAR-ligands such as bilirubin,
bile acids and steroid hormones. This will maintain the downstream
CAR target genes in an active mode and ensures a rapid and efficient
turnover of the xenobiotic metabolic pathway. In turn, the PAR
bZip genes are reported to act upstream of CAR thus connecting
these two clusters of genes. Finally, our data seem to connect
fundamental mammalian pathways such as xenobiotic metabolism,
lipid and energy homeostasis, body weight, circadian rhythm and
possibly longevity through regulation by the intestinal microbiota.
Consequently, to target the gut microbiota with nutritional
Gut Microbiota and Xenobiotics
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metabolites and tailor-made pre- and probiotics to modify drug
metabolizing capacity is an interesting challenge for the future.
Methods
Animals and treatment
NMRI mice were maintained on a standard R36 chow
(Lactamin, Sweden) in 12 hours light cycles. Male 9–12 weeks
old mice were used. Animals were raised either under germ-free
conditions (GF) in stainless steel isolators, or under conventional
conditions in a specific pathogen-free environment (SPF). The GF
status of the isolators was monitored weekly. A subset of the GF
animals was colonized with a complete flora, a procedure termed
conventionalization (Conv-D). The mice were sacrificed by
cervical dislocation, the livers were harvested, weighed and stored
in RNA later (Qiagen, Germany) at 280uC until RNA analysis, or
flash-frozen in liquid nitrogen.
Pentobarbital (5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyri-
midinetrione) was injected intraperitoneally, and the time between
loosing and subsequently retrieving the righting reflex was
assessed. Eleven GF and 26 SPF NMRI mice were tested. The
body- and liver weights were recorded post mortem. To assess the
time scale of the effect of the flora on the pentobarbital anesthesia
and liver size, GF mice were Conv-D for 1, 3, or 6 weeks (n = 4–
5/group) before pentobarbital-induced anesthesia and liver/body-
weight ratio were measured. Animal husbandry was in accordance
with institutional guidelines at Karolinska Institutet and all animal
experiments were approved by the animal ethics committee north
at Karolinska Institutet, Stockholm, Sweden.
RNA extraction
Total RNA was extracted using Qiagen RNeasy midi kit,
according to the manufacturer’s instructions and was stored at
280uC. RNA concentration and purity were determined using
Nanodrop at wavelength 260/280 nm and RNA integrity was
ensured using agarose gel electrophoresis.
TaqMan Low Density Array
Microarray analysis was carried out on the liver samples of SPF
and GF mice by using the Compugen mouse 22K oligonucleotide
arrays (NCBI tracking system#15583764). Transcript levels for 380
genes and the reference gene 18S rRNA (Table S1) were analyzed
by a Taqman low-density array (TLDA) to verify the microarray
results. Total RNA (1 mg) (n= 7 mice/group) was reverse tran-
scribed into cDNA by using a High-Capacity cDNA Archive Kit
(Applied Biosystems, Foster City, CA). The reverse transcriptase
reaction was performed at 25uC for 10 min and then 37uC for 2 h,
followed by 85uC for 5 s. Each cDNA sample (100 mg/50 ml) was
added to an equal volume of 2x Taqman Universal PCR Master
Mix (Applied Biosystems). The mixture was then transferred into a
loading port on a TLDA card (Applied Biosystems). The card was
centrifuged twice for 1 minute each at 1,200 rpm to distribute the
PCR mix from the loading port into the wells of the card. The card
was then sealed and PCR amplification was performed using an
Applied Biosystems Prism 7900HT sequence detection system.
Thermal cycler conditions were as follows: 50uC for 2 min with
100% ramping, 94.5uC for 10 min with 100% ramping, 40 cycles of
97uC for 30 s with 50% ramping, and 59.7uC for 1 min with 100%
ramping. The data was analyzed using the SDS2.2 software
(Applied Biosystems) where baseline and threshold settings were
automatically adjusted. The SAM (Statistical Analysis of Micro-
arrays) statistical method was used to select differentially expressed
genes. Genes were selected based on the q-value less than 5%.
Gene ontology clustering
SAM-generated differentially expressed gene lists were analyzed
for gene ontology information by using Ingenuity Pathways
Analysis (IPA) software (IngenuityH Systems, www.ingenuity.
com), which looks for both known canonical pathways and
networks of genes. For canonical pathways, the significance of the
association was measured in two ways: (i) by the ratio of the
number of genes from the data set that map to the pathway
divided by the total number of genes in that pathway and (ii) by
using the Fisher exact test to calculate a P value determining the
probability that the association between the genes in the data set
and the canonical pathway is explained by chance alone. For the
networks, Ingenuity Pathways analysis computes a score for each
network according to the fit of the user’s set of significant genes.
The score is derived from the likelihood that the focus genes in a
network are together due to chance alone. A score of 2 is
equivalent to a P value of 0.01.
Supporting Information
Table S1 List of genes tested with TLDA, including differen-
tially regulated genes in the livers of SPF compared to GF NMRI
mice.
Found at: doi:10.1371/journal.pone.0006958.s001 (0.09 MB
XLS)
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